Ticker name:ABTABBOTT LABORATORIES

Country: US-Sector: Healthcare, Industry: Medical - Devices

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Market Cap 177B

Last close 102.23$

Key metrics

Largest 20 companies In Medical - Devices

# PositionTickerCompany NameMarket CapLast PriceAction
1ABTABBOTT LABORATORIES177B102.23$
2ISRGINTUITIVE SURGICAL INC135B383.54$
3MDTMedtronic plc119B92.77$
4SYKSTRYKER CORP107B280.13$
5BSXBOSTON SCIENTIFIC CORP63B43.55$
6EWEdwards Lifesciences Corp51B88.25$
7DXCMDEXCOM INC33B87.93$
8RMDRESMED INC33B228.42$
9ZBHZIMMER BIOMET HOLDINGS, INC.18B94.25$
10PENPenumbra Inc13B318.87$
11SNNSMITH & NEPHEW PLC12B27.78$
12ALGNALIGN TECHNOLOGY INC11B149.71$
13BIOBIO-RAD LABORATORIES, INC.10B382.41$
14GMEDGLOBUS MEDICAL INC10B74.16$
15PODDINSULET CORP9.8B141.55$
16BRKRBRUKER CORP9.6B63.05$
17GKOSGLAUKOS Corp9.5B161.42$
18ITGRInteger Holdings Corp4.3B126.33$
19LIVNLivaNova PLC4.3B77.79$
20IRTCiRhythm Holdings, Inc.3.7B111.75$